The recent introduction of biologic and targeted synthetic disease-modifying drugs has led to more specificity in the treatment of autoimmune diseases; however, they require continuous or intermittent administration, are associated with cumulative risks for side effects, result in high costs and provide no cure. In contrast, high-dose chemotherapy followed by transplantation of autologous hematopoietic stem cells (AHSCT) has been demonstrated to induce clinical remission in various autoimmune diseases that can persist over many years without continued maintenance therapy. The principle behind AHSCT is an elimination of important components of the autoreactive immunological memory with subsequent regeneration of the complete immune system. Several studies have indicated that such an immune reset is associated with fundamental changes in the immune repertoire leading to an induction of tolerance against self-antigens. This article presents the current indications of AHSCT for autoimmune diseases based on the registry data of the European Society of Blood and Marrow Transplantation (EBMT) and discusses the results from mechanistic studies, which provide detailed insights into the mode of action of this treatment.
Keywords: EBMT; Immune reconstitution; Immune reset; Stem cell therapy; Stem cell transplantation.
Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in refractory Takayasu arteritis: a retrospective multicenter case-series from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT).Bone Marrow Transplant. 2020 Apr 22. doi: 10.1038/s41409-020-0907-4. Online ahead of print. Bone Marrow Transplant. 2020. PMID: 32322038
Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT).Bone Marrow Transplant. 2017 Aug;52(8):1133-1137. doi: 10.1038/bmt.2017.40. Epub 2017 Mar 20. Bone Marrow Transplant. 2017. PMID: 28319075
Immune Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Crohn's Disease: Current Status and Future Directions. A Review on Behalf of the EBMT Autoimmune Diseases Working Party and the Autologous Stem Cell Transplantation In Refractory CD-Low Intensity Therapy Evaluation Study Investigators.Front Immunol. 2018 Apr 4;9:646. doi: 10.3389/fimmu.2018.00646. eCollection 2018. Front Immunol. 2018. PMID: 29670622 Free PMC article. Review.
Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases: From Mechanistic Insights to Biomarkers.Front Immunol. 2018 Nov 16;9:2602. doi: 10.3389/fimmu.2018.02602. eCollection 2018. Front Immunol. 2018. PMID: 30505303 Free PMC article. Review.
Resetting the immune response after autologous hematopoietic stem cell transplantation for autoimmune diseases.Curr Res Transl Med. 2016 Apr-Jun;64(2):107-13. doi: 10.1016/j.retram.2016.03.004. Epub 2016 Jun 1. Curr Res Transl Med. 2016. PMID: 27316394 Review.